News Service

late-breaking news in healthcare

National Guideline Clearinghouse No Longer Available After July 16, 2018

April 24, 2018 News Service

The Agency for Healthcare Research and Quality (AHRQ) announced on Monday that their National Guideline Clearinghouse (NGC) Website will not be available after July 16, 2018 due to lack of federal funding.

FDA News Briefs for Monday, April 23, 2018

April 23, 2018 News Service

These Food and Drug Administration (FDA) developments came in late last week.

FDA News Briefs for Friday, April 20, 2018

April 20, 2018 News Service

These Food and Drug Administration (FDA) developments came in earlier this week.  

FDA Approves Crysvita for Treatment of X-Linked Hypophosphatemia

April 19, 2018 News Service

The Food and Drug Administration (FDA) has approved Crysvita (burosumab-twza; Ultragenyx Pharmaceutical) for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older.

FDA Approves Opdivo Plus Yervoy Frontline Combo for Advanced Renal Cancer

April 18, 2018 News Service

The Food and Drug Administration (FDA) announced on Tuesday the approval of a new combination regimen for the first-line treatment of intermediate- and poor-risk patients with advanced renal cell carcinoma.  

FDA Approves Novel Organ Care System for Donor Lung Preservation

April 17, 2018 News Service

The Food and Drug Administration (FDA) has approved the Organ Care System (OCS) Lung (TransMedics, Inc.), a portable organ perfusion, ventilation, and monitoring device indicated for the preservation of standard criteria donor lungs in a near physiologic, ventilated, and perfused state for double lung transplantation.    

FDA News Briefs for Monday, April 16, 2018

April 16, 2018 News Service

These Food and Drug Administration (FDA) developments came in late last week.

FDA News Briefs for Thursday, April 12, 2018

April 12, 2018 News Service

These Food and Drug Administration (FDA) developments came in earlier this week.

FDA Restricts Sales of Essure Contraceptive Implant

April 11, 2018 News Service

On April 9, 2018, the Food and Drug Administration (FDA) announced it would require Bayer to restrict the sale and distribution of its Essure permanent birth control implant to medical practices that agree to fully inform women about the device’s risks and benefits as specified in newly approved product labeling.

CDC Warns of Vitamin K-Dependent Coagulopathy Outbreak Linked to Synthetic Cannabinoids

April 10, 2018 News Service

The Centers for Disease Control and Prevention (CDC) has released an outbreak bulletin for a potential life-threatening vitamin K-dependent coagulopathy that has been associated with the use of synthetic cannabinoids.